<img alt="" src="https://secure.perk0mean.com/184386.png" style="display:none;">

Download your FREE copy of “Temperature Monitoring Challenges in the Clinical Supply Chain” today

The clinical supply chain of investigational medicinal products (IMPs) is complex. The time from designing and packaging a kit through to it reaching the patient can take several months. Thus, management of the temperature exposure of a sensitive IMP is critical.

  • Temperature deviations can put patients’ health and their participation in the study at risk.
  • Following a temperature excursion, kits are quarantined until the viability is determined, which could result in their destruction if they are deemed unfit for use.
  • An IMP supply chain where the temperature control is robust is therefore a vital asset.